What is Equinom?
Founded in 2012 and headquartered in Givat Brenner, Israel, Equinom operates at the intersection of biotechnology and food science. The company specializes in breeding non-GMO varieties of primary crops, such as pea and soy, specifically optimized for food production. Unlike traditional breeding methods, Equinom’s Manna platform utilizes sophisticated data analytics to identify and enhance biochemical and genomic traits, resulting in ingredients that offer superior taste, texture, and nutritional profiles. This approach significantly reduces the complexity and cost of downstream processing, positioning Equinom as a critical enabler for food manufacturers seeking to scale affordable, high-quality plant-based alternatives to meat and dairy products.
How much funding has Equinom raised?
Equinom has raised a total of $73M across 5 funding rounds:
Series A
$4M
Other Financing Round
$4M
Series B
$10M
Series C
$20M
Other Financing Round
$35M
Series A (2017): $4M with participation from Fortissimo Capital
Other Financing Round (2018): $4M led by Fortissimo Capital
Series B (2020): $10M supported by Roquette, Fortissimo Capital, BASF Venture Capital, and Trendlines Group
Series C (2021): $20M featuring Maverick, BASF Venture Capital, Phoenix Group, Fortissimo, and Trendlines
Other Financing Round (2022): $35M backed by Praesidium and Synthesis Capital
Key Investors in Equinom
Synthesis Capital
A venture capital firm specializing in the food technology and biotechnology sectors, with a specific focus on transforming the global food system through alternative protein solutions.
BASF Venture Capital
The corporate venture capital arm of the BASF Group, focusing on strategic investments in biotechnology, circular economy, and sustainable materials to foster industrial innovation.
Trendlines Group
An investment firm that incubates and supports innovation-based medtech and agrifood technologies, providing hands-on guidance from technology development to commercialization.
What's next for Equinom?
With the infusion of recent capital, Equinom is well-positioned to scale its operations and expand its footprint in the global food ingredients market. The company's strategic roadmap focuses on deepening its R&D capabilities to broaden its portfolio of optimized crop varieties, thereby addressing the growing demand for sustainable food systems. As the industry shifts toward cleaner labels and reduced processing, Equinom’s ability to deliver high-protein, functional ingredients without genetic modification provides a distinct competitive advantage. Future growth will likely involve deepening partnerships with major food conglomerates and scaling the deployment of its Manna technology to meet the increasing global appetite for plant-based innovation.
See full Equinom company page
